⌘K

Home/Insiders/Perry Andrew

PA

SEC Insider//CIK 0001877793

Perry Andrew

CIK 00018777931 companyRESEARCH TRIANGLE PARK, NC

Transactions

12

Companies

1

Filings

5

CIK

0001877793

Recent Transactions

12 trades

Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−114,482→ 14,232 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−67,050→ 0 total
Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−14,232→ 0 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-09-18+16,100→ 128,714 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−32,100→ 0 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-07-05$2.51/sh−1,337→ 112,614 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-07-01+35,000→ 113,951 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-05-13$4.79/sh−8,151→ 78,951 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−379→ 89,136 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-01-03+33,570→ 89,515 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-01-03+67,050→ 67,050 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−2,034→ 87,102 total

Companies

1

G1 Therapeutics, Inc.
Chief Commercial Officer

Recent Filings

5

Address

700 PARK OFFICES DRIVE, SUITE 200

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov